350 related articles for article (PubMed ID: 21826785)
1. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Turaka K; Shields CL; Meadows AT; Leahey A
Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
Lambert MP; Shields C; Meadows AT
Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
[TBL] [Abstract][Full Text] [Related]
3. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of primary chemotherapy in retinoblastoma.
Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
[TBL] [Abstract][Full Text] [Related]
5. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).
Luna-Fineman S; Barnoya M; Bonilla M; Fu L; Baez F; Rodríguez-Galindo C
Pediatr Blood Cancer; 2012 Apr; 58(4):545-50. PubMed ID: 21910211
[TBL] [Abstract][Full Text] [Related]
7. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.
Chantada GL; Fandiño AC; Raslawski EC; Manzitti J; de Dávila MT; Casak SJ; Scopinaro MJ; Schvartzman E
Pediatr Blood Cancer; 2005 May; 44(5):455-60. PubMed ID: 15558702
[TBL] [Abstract][Full Text] [Related]
8. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for intraocular retinoblastoma in Malaysia.
Menon BS; Juraida E; Alagaratnam J; Mohammad M; Ibrahim H; George TM; Ariffin H; Ho C; Khuzaiah R; Peng LH
J Pediatr Hematol Oncol; 2007 Jan; 29(1):2-4. PubMed ID: 17230058
[TBL] [Abstract][Full Text] [Related]
10. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
11. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
12. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
[TBL] [Abstract][Full Text] [Related]
13. The success of primary chemotherapy for group D heritable retinoblastoma.
Cohen VM; Kingston J; Hungerford JL
Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
[TBL] [Abstract][Full Text] [Related]
14. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
[TBL] [Abstract][Full Text] [Related]
15. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
[TBL] [Abstract][Full Text] [Related]
16. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
[TBL] [Abstract][Full Text] [Related]
18. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
20. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]